| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
37,157 |
33,258 |
$2.37M |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
47,046 |
41,814 |
$1.90M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
47,259 |
42,864 |
$1.17M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
31,226 |
28,381 |
$1.13M |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
56,878 |
50,495 |
$1.10M |
| G0482 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed |
8,646 |
7,498 |
$1.03M |
| 62323 |
|
3,989 |
3,223 |
$455K |
| 99442 |
|
8,036 |
6,561 |
$236K |
| 99441 |
|
11,624 |
9,321 |
$230K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
3,974 |
3,461 |
$213K |
| 27096 |
|
937 |
759 |
$195K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,864 |
1,650 |
$145K |
| J2704 |
Injection, propofol, 10 mg |
7,569 |
5,628 |
$72K |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
7,066 |
5,382 |
$56K |
| 90832 |
Psychotherapy, 30 minutes with patient |
1,734 |
1,218 |
$45K |
| 90791 |
Psychiatric diagnostic evaluation |
546 |
429 |
$29K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
2,111 |
1,895 |
$28K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
1,739 |
1,408 |
$18K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
3,744 |
3,128 |
$18K |
| A9279 |
Monitoring feature/device, stand-alone or integrated, any type, includes all accessories, components and electronics, not otherwise classified |
6,560 |
5,688 |
$18K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
7,557 |
6,446 |
$17K |
| 64493 |
|
87 |
77 |
$12K |
| 81025 |
|
2,151 |
1,933 |
$11K |
| 96127 |
|
4,224 |
3,695 |
$11K |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
6,557 |
5,058 |
$10K |
| 96160 |
|
4,198 |
3,676 |
$9K |
| A4550 |
Surgical trays |
6,662 |
5,840 |
$8K |
| 64635 |
|
29 |
25 |
$8K |
| A4556 |
Electrodes, (e.g., apnea monitor), per pair |
3,382 |
2,997 |
$8K |
| 99443 |
|
175 |
138 |
$7K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
142 |
129 |
$7K |
| 62321 |
|
39 |
37 |
$6K |
| 90833 |
Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) |
269 |
253 |
$6K |
| J3490 |
Unclassified drugs |
17,702 |
7,945 |
$6K |
| 64636 |
|
47 |
24 |
$5K |
| A4930 |
Gloves, sterile, per pair |
6,608 |
5,802 |
$2K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
54 |
50 |
$2K |
| 64494 |
|
30 |
26 |
$2K |
| A4247 |
Betadine or iodine swabs/wipes, per box |
208 |
203 |
$802.77 |
| 20553 |
|
29 |
25 |
$754.13 |
| 76942 |
|
15 |
13 |
$587.91 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
19 |
17 |
$483.05 |
| 82962 |
|
253 |
199 |
$444.05 |
| 82627 |
|
20 |
18 |
$434.83 |
| 77003 |
|
89 |
70 |
$366.25 |
| 82533 |
|
20 |
18 |
$318.80 |
| A4209 |
Syringe with needle, sterile 5 cc or greater, each |
2,229 |
1,954 |
$298.99 |
| 82607 |
|
19 |
17 |
$276.03 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
374 |
255 |
$246.54 |
| 83525 |
|
16 |
14 |
$164.85 |
| A4215 |
Needle, sterile, any size, each |
3,124 |
2,738 |
$129.73 |
| 36415 |
Collection of venous blood by venipuncture |
20 |
18 |
$51.18 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
17 |
13 |
$2.52 |